Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Confounded pathways
BPC-157 and Thymosin Beta-4 have complementary but mechanistically distinct profiles in the published literature
The study had no placebo group, no randomisation, no blinding, no imaging-confirmed repair endpoint and no clear analytical confirmation that the second peptide was the defined TB-500 fragment
Potential risks and contraindications Given the limited understanding of DSIPs mechanisms and effects in humans, certain risks and contraindications must be taken into consideration: Unknown long-term effects : The long-term safety of DSIP has not been well-established, and the potential risks associated with chronic use remain unclear
US$ 29.81
US$ 20.93
US$ 20.56
US$ 24.52
US$ 21.39
US$ 24.63
